Oric Pharmaceuticals, Inc. ORIC Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s net income?
- Oric Pharmaceuticals, Inc. (ORIC) reported net income of -$35.77M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s net income changed year-over-year?
- Oric Pharmaceuticals, Inc.'s net income decreased by 19.1% year-over-year, from -$30.02M to -$35.77M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s net income has grown at a 13.2% compound annual growth rate (CAGR), from -$78.72M to -$129.47M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.